Novel plasma biomarker of atenolol-induced hyperglycemia identified through a metabolomics-genomics integrative approach

INTRODUCTION: While atenolol is an effective antihypertensive agent, its use is also associated with adverse events including hyperglycemia and incident diabetes that may offset the benefits of blood pressure lowering. By combining metabolomic and genomic data acquired from hypertensive individuals...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Metabolomics
Main Authors: de Oliveira, Felipe A., Shahin, Mohamed H., Gong, Yan, McDonough, Caitrin W., Beitelshees, Amber L., Gums, John G., Chapman, Arlene B., Boerwinkle, Eric, Turner, Stephen T., Frye, Reginald F., Fiehn, Oliver, Kaddurah-Daouk, Rima, Johnson, Julie A., Cooper-DeHoff, Rhonda M.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5310671/
https://ncbi.nlm.nih.gov/pubmed/28217400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11306-016-1076-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker